Based on the results in this study, we conclude that the combination of high MPO positive cell density and IL-17 expression enhances the indicative value for the response of ovarian carcinomas to chemotherapy, as it in addition has prognostic value regarding recurrence-free survival in ovarian carcinoma. This evidence concerns the gene MPO and ovarian carcinoma.